By Max Mitchell | September 13, 2017
The judge overseeing pelvic mesh mass tort litigation said the New Jersey-based defendant may have had a "strong" relationship with a Pennsylvania mesh-manufacturer, but he questioned whether that relationship would be enough to allow the Keystone State to retain jurisdiction over 90 pelvic mesh cases involving out-of-state plaintiffs.
By Tom McParland | September 13, 2017
The former head of Valeant Pharmaceuticals International Inc.' s dermatology division was unable to convince a court to end a class action lawsuit accusing the generic drugmaker and its executives of engaging in a massive scheme to fraudulently inflate the company's stock prices.
By Max Mitchell | September 11, 2017
Attorneys have characterized the recent U.S. Supreme Court decision in as game-changing for mass tort programs in state court, but lawyers for more than 90 plaintiffs suing Johnson & Johnson over their pelvic mesh products have said in court papers the ruling should not affect the mass tort program pending in Philadelphia.
By Lizzy McLellan | September 8, 2017
Two aspiring medical marijuana companies have filed lawsuits against the Pennsylvania Department of Health over its medical cannabis licensing process. And one of them is seeking to take the permit awarded to another licensed grower/processor after its parent company was implicated in a criminal investigation.
By Max Mitchell | September 8, 2017
A federal circuit court has rejected attempts by Pennsylvania medical device makers to unseal records that were part of a grand jury investigation that resulted in officials from those companies pleading guilty to unlawful off-label marketing.
By Max Mitchell | September 7, 2017
A federal court has allowed a proposed class action to go forward against CVS Pharmacy over allegations its technicians were not paid for time spent working on a mandatory online training course.
By P.J. D'Annunzio | August 25, 2017
Several Chinese nationals, including two scientists who worked for GlaxoSmithKline, charged with stealing cancer medication trade secrets from the drugmaker are set to stand trial next year.
By Max Mitchell | August 22, 2017
A fight over whether 90 pelvic mesh cases pending in Philadelphia state court against a Johnson & Johnson subsidiary should be transferred to other jurisdictions in the wake of the U.S. Supreme Court's game-changing decision in is focusing on the defendant's contacts with a third-party mesh supplier that is based in Pennsylvania.
By thelegalintelligencer | The Legal Intelligencer | August 18, 2017
Under the clear and unambiguous terms of the parties' retainer agreement, the New Jersey-based defendant consented to the jurisdiction of the Pennsylvania court, agreed to be bound by Pennsylvania law and consented to the entry of a confessed judgment in any court. The court denied defendant's motion to dismiss for lack of jurisdiction.
By Max Mitchell | August 17, 2017
Mylan has agreed to pay $465 million to settle claims that the Pennsylvania-based drugmaker misclassified its EpiPen allergy medication to avoid paying Medicaid rebates.
Presented by BigVoodoo
The Legal Intelligencer honors lawyers leaving a mark on the legal community in Pennsylvania and Delaware.
Consulting Magazine recognizes leaders in technology across three categories Leadership, Client Service and Innovation.
Celebrate outstanding achievement in law firms, chambers, in-house legal departments and alternative business structures.
We are seeking an associate to join our Employee Benefits practice. Candidates should have three to six years of employee benefits experienc...
Associate attorney position at NJ Immigration Law firm: Leschak & Associates, LLC, based in Freehold, NJ, is looking for a full time ass...
Duane Morris LLP has an immediate opening for a senior level, highly motivated litigation associate to join its dynamic and growing Employme...
MELICK & PORTER, LLP PROMOTES CONNECTICUT PARTNERS HOLLY ROGERS, STEVEN BANKS, and ALEXANDER AHRENS